Newsroom | 6024 results
Sorted by: Latest
-
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026...
-
Corner Health Announces $32.5 Million in Seed and Series A Financing to Help Independent Clinicians Rebuild Primary Care
LOS ANGELES--(BUSINESS WIRE)--Corner Health, a company designed to rebuild the healthcare system by empowering Nurse Practitioners (NPs) to start and scale their own local primary care practices, announced today it has raised $32.5 million in Seed and Series A financing. Their recent Series A was led by Oak HC/FT, with participation from existing investors First Round Capital and Zigg Capital. The investment follows a period of rapid growth for Corner Health, which has established a network of...
-
AIS Healthcare Targeted Drug Delivery Named 2025 Pioneer in URAC’s Leaders in Performance Measurement Recognition Program
DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery and infusion care solutions, announced today that its Targeted Drug Delivery division has been recognized as a 2025 Pioneer in URAC's Leaders in Performance Measurement (LPM) recognition program. This honor is awarded to URAC-accredited organizations who demonstrate leadership in measuring and improving the quality of patient care through performance measurement. The recognition follows URAC's annual review of...
-
HealthTrust Honors Supplier Partners for Driving Innovation, Value and Performance in 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) today announced AirLife®, Philips, American Express and CSL Behring as recipients of its 2026 Supplier of the Year Awards. A presentation of the awards will take place at the annual HealthTrust University Conference (HTU) on July 21 in Denver, Colorado. As part of efforts to make missions possible for health systems, the awards acknowledge the outstanding support, service and value supplier partners deliver to Healt...
-
Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol
DOVER, Del.--(BUSINESS WIRE)--Precisio announced the continuation of its expanded access program, with dosing of a staph lysin called ClyO (LYSG101) to a patient with chronic prosthetic joint infection. Under an FDA-approved expanded-access IND, administration of ClyO was initiated on June 1. The treatment follows a 4 month protocol with a minimum 6 month follow-up. Outcomes to be tracked include safety, improvements of clinical signs and symptoms, and either durable eradication or sustained sup...
-
OpenEvidence and NewYork-Presbyterian, Columbia University and Weill Cornell Medicine Expand Clinical AI Tools Across New York City and Westchester
MIAMI & NEW YORK--(BUSINESS WIRE)--OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, today announced a collaboration with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region. This enterprise-scale collaboration will place trusted, evidence-based clinical AI in the hands o...
-
Olio and Cantex Raise the Standard for Skilled Nursing Care Transitions Across Texas
INDIANAPOLIS--(BUSINESS WIRE)--Olio today announced that Cantex Continuing Care Network will deploy Olio across its Texas SNF portfolio and its Theracare Home Health Agencies to manage census, coordinate outbound referrals, and turn downstream network insights into a competitive advantage. The rollout marks a major step in Cantex's strategy to lead the next era of value-based, post-acute care. Olio is the only platform built to transform how SNFs manage patient transitions, from intake referral...
-
OpenEvidence, Anticoagulation Forum Partner to Expand Access to AI-Enabled Guidance in Antithrombotic Care
MIAMI & BOSTON--(BUSINESS WIRE)--OpenEvidence and the Anticoagulation Forum (AC Forum) today announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By combining the AC Forum’s leadership in education and multidisciplinary clinical guidance with OpenEvidence’s advanced artificial intelligence platform, clinicians will gain access to timely and practical evidence in antithrombotic therapy. “Clinicians are increasingly turn...
-
Flying Angels to Exhibit at USCIPP 2026 Annual Meeting in Philadelphia
PHILADELPHIA--(BUSINESS WIRE)--Flying Angels will exhibit at the USCIPP 2026 Annual Meeting to highlight its bedside-to-bedside medical transport services....
-
Frazier Healthcare Partners Announces Definitive Agreement to Acquire MatrixCare
SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners ("Frazier"), a private equity firm focused exclusively on the healthcare industry, today announced it has entered into a definitive agreement to acquire MatrixCare (the “Company”) from Resmed (NYSE & ASX: RMD).MatrixCare is a leading provider of cloud-based EHR software purpose-built for out-of-hospital care settings, including skilled nursing, senior living, home health, hospice, and life plan communities. A multi-year winner of the Best...